Overview

Adalimumab for Inflammatory Osteoarthritis

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
We will conduct a pilot study of the effectiveness of adalimumab for inflammatory osteoarthritis.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Alberta
Treatments:
Adalimumab